Pimentel, Franklin Fernandes, et al. “SYNERGISTIC MECHANISMS OF ACTION: COMPARISON OF ADCC AND SIGNALING PATHWAYS INHIBITION BY TRASTUZUMAB BIOSIMILAR OR ORIGINATOR TRASTUZUMAB IN COMBINATION WITH PERTUZUMAB IN HER2+ BREAST CANCER CELL LINES”. Mastology, vol. 31, Oct. 2021, p. 9, https://revistamastology.emnuvens.com.br/revista/article/view/981.